NPY and obesity due to melanocortin 4 receptor deficiency: Y1R-preferring NPY analogs with potential therapeutic applications are used to unravel the signaling mediated by this receptor in health and diseases (e.g., cancer, mood disorders, obesity, stress response, food intake) [250,251,252,253,254].